Reckitt Benckiser Group (RBGLY) Fair Value & Analysis
Consumer Defensive · US · Market cap $39.5B
Reckitt Benckiser Group
RBGLY · US
Fair value as of: Aug 13, 2026
From 23 valuation models · updated today
Fair value updated Aug 13, 2026, revised from $17.69 to $17.42 (−1.5%) since Jul 18, 2026. Share price +4.9% over the past month.
A strong business, screening 24% undervalued on our models.
What matters now
- The model range is unusually wide ($10.97 to $29.82). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Our model range runs from $10.97 (bear) to $29.82 (bull), base $17.42. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 77/100 (high quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range $9.50 – $17.36 · fair‑value band $10.97 – $29.82 · the $14.03 price screens below the $17.42 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Reckitt Benckiser Group (RBGLY) currently trades at $14.03, while our model-based Fair Value estimate is $17.42, implying the stock looks roughly 24.2% undervalued today. The Quality Score stands at 77/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Reckitt Benckiser Group generated revenue of $14.2B at a net margin of 22.4%. Revenue declined 2.6% year over year. It earns a return on equity of 44.2%. Net debt stands at $6.5B. Fundamentals as of Aug 13, 2026
Our scenario range runs from $10.97 (bear case) to $29.82 (bull case); at $14.03, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 19% below its 52-week high and 17% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -38% fair-value upside, at 24%, RBGLY screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 23 models by family
Widest divergence: Growth Earnings ($16.98) versus Asset-Based ($1.63). Highest evidence: Growth DCF (80).
Notify me when RBGLY reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 70 · Market factors (momentum, volatility) 52
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names.
Full company description
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Reckitt Benckiser Group reported revenue of $13.9B in FY2025 versus $13.2B in FY2021, a compound +1.2%/yr. Reported net income was $3.1B in FY2025.
of which total revenue +5.1 pp · buybacks/dilution +0.5 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch RBGLY: get an alert when its fair value changes →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Reckitt Announces Pricing Terms for Previously Announced Any and All Tender Offer and Consent Solicitation for Mead Johnson Nutrition Compan
- Reckitt Benckiser Group PLC's Dividend Analysis
- Reckitt Announces Any and All Tender Offer and Consent Solicitation for Mead Johnson Nutrition Company Notes due 2044
- Reckitt Benckiser Group PLC (RBGLY) (H1 2026) Earnings Call Highlights: Strong Q2 Performance ...
Peer Group
Household & Personal Products · 251 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | $146.80 | $108.16 | -26% |
| Unilever PLC ULN | 1,080 MXN | 973.58 MXN | -10% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,063 | ₹789.46 | -62% |
| Essity AB ESSITYA | kr 276.50 | kr 250.02 | -10% |
| Godrej Consumer Products Limited GODREJCP | ₹936.90 | ₹367.64 | -61% |
| Marico Limited MARICO | ₹855.00 | ₹233.05 | -73% |
| APR Co 278470 | 397,000 KRW | 137,521 KRW | -65% |
| Dabur India Limited DABUR | ₹411.25 | ₹175.59 | -57% |
| PT Unilever Indonesia Tbk UNVR | 1,760 IDR | 1,928 IDR | +10% |
| Amorepacific Corporation 090430 | 135,700 KRW | 84,785 KRW | -38% |
Compare Reckitt Benckiser Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Reckitt Benckiser Group (RBGLY) overvalued or undervalued?
What is the fair value of RBGLY?
What is the quality score of RBGLY?
What is the revenue of Reckitt Benckiser Group (RBGLY)?
What is the net profit margin of RBGLY?
Does Reckitt Benckiser Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Reckitt Benckiser Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.